GRACE THERAPEUTICS INC (GRCE) Stock Income Statement
USA - NASDAQ:GRCE - US00439U1043 - Common Stock
3.19 USD
+0.05 (+1.59%)
| TTM (2025-6-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | |||
| Cost Of Goods | N/A | N/A | N/A | 0.00 | 80.00K | |||
| Gross Profit | N/A | N/A | N/A | 0.00 | 120.00K | |||
| Operating Expenses | 14.81M | 11.37M | 18.25M | 15.34M | 10.84M | |||
| Research and Development | 1.14M | 1.04M | 2.33M | 2.46M | 1.81M | |||
| Selling, General, and Administrative Expenses | 7.04M | 6.64M | 8.21M | 9.78M | 6.66M | |||
| Operating Income | -14.81M | -11.37M | -18.25M | -15.34M | -10.72M | |||
| Interest Income/Expense | 2.02M | -1.83M | 180.00K | 4.98M | -3.00M | |||
| Other Income/Expense | N/A | N/A | 0.00 | 150.00K | -260.00K | |||
| Non Recurring Items | N/A | -1.49M | -33.91M | -250.00K | -5.70M | |||
| Income Before Taxes | -12.79M | -14.69M | -51.97M | -10.47M | -19.68M | |||
| Income Tax | -2.48M | -1.83M | -9.54M | -650.00K | N/A | |||
| Net Income | -10.31M | -12.85M | -42.43M | -9.82M | -19.68M | |||
| EBITDA | -14.80M | -11.36M | -18.13M | N/A | -9.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.82 | -1.35 | -5.71 | -1.60 | -7.96 | |||
| Non GAAP EPS | -0.70 | -0.85 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 60.00% | |||
| Profit Margin | N/A | N/A | N/A | N/A | -9840.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -5360.00% | |||
All data in USD